Z Asemi1, M Samimi2, Z Tabassi2, A Esmaillzadeh3. 1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran. 2. Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran. 3. 1] Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran [2] Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract
BACKGROUND/ OBJECTIVES: The current study was performed to investigate the effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on pregnancy outcomes in pregnant women with gestational diabetes mellitus (GDM). SUBJECTS/ METHODS: This randomized controlled clinical trial was performed among 52 women diagnosed with GDM. Participants were randomly assigned to consume either the control (n=26) or the DASH diet (n=26) for 4 weeks. The control diet was designed to contain 45-55% carbohydrates, 15-20% protein and 25-30% total fat. The DASH diet was rich in fruits, vegetables, whole grains and low-fat dairy products, and contained lower amounts of saturated fats, cholesterol and refined grains with a total of 2400 mg/day sodium. The numbers of women who commenced insulin therapy after dietary intervention, the mode of delivery and prevalence of polyhydramnios were assessed. The length, weight and head circumference of infants were measured during the first 24 h after birth. RESULTS: Whereas 46.2% of women in the DASH diet needed to have a cesarean section, this percentage for the control group was 80.8% (P=0.01). The percentage of those who needed to commence insulin therapy after intervention was also significantly different between the two groups (23% for DASH vs 73% for control group, P<0.0001). Infants born to mothers on theDASH diet had significantly lower weight (3222.7 vs 3818.8 g, P<0.0001), head circumference (34.2 vs 35.1 cm, P=0.01) and ponderal index (2.50 vs 2.87 kg/m(3), P<0.0001) compared with those born to mothers on the control diet. CONCLUSIONS: In conclusion, consumption of DASH diet for 4 weeks among pregnant women withGDM resulted in improved pregnancy outcomes.
RCT Entities:
BACKGROUND/ OBJECTIVES: The current study was performed to investigate the effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on pregnancy outcomes in pregnant women with gestational diabetes mellitus (GDM). SUBJECTS/ METHODS: This randomized controlled clinical trial was performed among 52 women diagnosed with GDM. Participants were randomly assigned to consume either the control (n=26) or the DASH diet (n=26) for 4 weeks. The control diet was designed to contain 45-55% carbohydrates, 15-20% protein and 25-30% total fat. The DASH diet was rich in fruits, vegetables, whole grains and low-fat dairy products, and contained lower amounts of saturated fats, cholesterol and refined grains with a total of 2400 mg/day sodium. The numbers of women who commenced insulin therapy after dietary intervention, the mode of delivery and prevalence of polyhydramnios were assessed. The length, weight and head circumference of infants were measured during the first 24 h after birth. RESULTS: Whereas 46.2% of women in the DASH diet needed to have a cesarean section, this percentage for the control group was 80.8% (P=0.01). The percentage of those who needed to commence insulin therapy after intervention was also significantly different between the two groups (23% for DASH vs 73% for control group, P<0.0001). Infants born to mothers on the DASH diet had significantly lower weight (3222.7 vs 3818.8 g, P<0.0001), head circumference (34.2 vs 35.1 cm, P=0.01) and ponderal index (2.50 vs 2.87 kg/m(3), P<0.0001) compared with those born to mothers on the control diet. CONCLUSIONS: In conclusion, consumption of DASH diet for 4 weeks among pregnant women with GDM resulted in improved pregnancy outcomes.
Authors: Anne Merewood; Supriya D Mehta; Tai C Chen; Howard Bauchner; Michael F Holick Journal: J Clin Endocrinol Metab Date: 2008-12-23 Impact factor: 5.958
Authors: Jamy D Ard; Steve C Grambow; Di Liu; Cris A Slentz; William E Kraus; Laura P Svetkey Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: Simone Kew; Chang Ye; Mathew Sermer; Philip W Connelly; Anthony J G Hanley; Bernard Zinman; Ravi Retnakaran Journal: Diabetes Care Date: 2011-10-04 Impact factor: 19.112
Authors: Yeyi Zhu; Sjurdur F Olsen; Pauline Mendola; Thorhallur I Halldorsson; Edwina H Yeung; Charlotta Granström; Anne A Bjerregaard; Jing Wu; Shristi Rawal; Jorge E Chavarro; Frank B Hu; Cuilin Zhang Journal: Am J Clin Nutr Date: 2017-06-07 Impact factor: 7.045
Authors: Emma M Rosen; Chantel L Martin; Anna Maria Siega-Riz; Nancy Dole; Patricia V Basta; Myrna Serrano; Jennifer Fettweis; Michael Wu; Shan Sun; John M Thorp; Gregory Buck; Anthony A Fodor; Stephanie M Engel Journal: Paediatr Perinat Epidemiol Date: 2021-11-28 Impact factor: 3.980
Authors: Meghana D Gadgil; Samantha F Ehrlich; Yeyi Zhu; Susan D Brown; Monique M Hedderson; Yvonne Crites; Assiamira Ferrara Journal: J Womens Health (Larchmt) Date: 2018-10-30 Impact factor: 2.681